Combining BRAFV600E inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0625|24|9|709-710

ISSN： 0906-6705

Source： EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol.24, Iss.9, 2015-09, pp. : 709-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 12, 2015-12 ,pp. : 2436-2443

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRAFV600E and NRASQ61L/Q61R mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting

By  

HISTOPATHOLOGY, Vol. 69, Iss. 4, 2016-10 ,pp. : 680-686

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 2, 2015-02 ,pp. : 155-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diffuse melanosis cutis in the setting of BRAFV600E mutant melanoma and treatment with targeted therapies

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 56, Iss. 2, 2015-05 ,pp. : 128-130

John Wiley & Sons Inc

Access to resources Recommend Favorite

Absence of BRAFV600E mutation in odontogenic keratocysts

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 47, Iss. 2, 2018-02 ,pp. : 186-191

John Wiley & Sons Inc

Access to resources Recommend Favorite